A high-level overview of Sel-Leb Marketing, Inc. (SELB-OLD) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals. Stock price history for Selecta Biosciences. Coherus BioSciences and Mark Cuban's drug company aim to disrupt Humira-Referenced Biosimilar space with launch of Yusimry at a 85% discount. Stock Information · Financial Information · Corporate Governance · Investor Selecta Biosciences Announces Merger with Cartesian Therapeutics - Read More. The Selecta Biosciences stock price may drop from USD to USD. The change will be %. Will SELB stock price grow / rise / go up?
SELB Selecta Biosciences is falling or rising technical reasons. Technical analysis forecast for Selecta Biosciences Stock is that its in a downtrend for. Selecta's current pipeline features SVP-enabled enzyme, oncology, and gene therapies. Leading the pipeline is SEL, a promising candidate in Phase 2 trials. Selecta Biosciences, Inc. (NASDAQ: SELB) (the Company) today announced that it has merged with Cartesian Therapeutics, Inc., a clinical-stage biotechnology. According to Selecta Biosciences, Inc.'s latest financial reports and current stock price. The company's current Enterprise Value is M. This represents a. The average one-year price target for Selecta Biosciences Inc is $ The forecasts range from a low of $ to a high of $ A stock's price target is. This small-cap Biotech is a sneaky play on next-gen drugs. Selecta Biosciences is one of the most mature companies in an area attracting the attention of. What is the market capitalization of Selecta Biosciences Inc Stock? As of the Feb 12, , the market capitalization of Selecta Biosciences Inc is M. Selecta Biosciences, Inc. (SELB) Dividends Stock symbol SELB is outdated, potentially delisted? Maybe it is available on other exchange? New to Digrin? See. Should value investors buy Selecta Biosciences stock? (SELB) share price, free cash flow, and discounted present value analysis. Should You Buy or Sell Selecta Biosciences Stock? Get The Latest SELB Stock Analysis, Price Target, Earnings Estimates, Headlines, and Short Interest at. Based on the financial report for Jun 30, , Selecta Biosciences Inc's Stock-Based Compensation amounts to m USD. What is Selecta Biosciences Inc's Stock.
As of November 13, , Selecta Biosciences, Inc. was acquired by Cartesian Therapeutics, Inc., in a reverse merger transaction. Selecta Biosciences, Inc. The average price target is $ with a high forecast of $ and a low forecast of $ The average price target represents a % change from the last. Selecta Biosciences, Inc. (SELB): $ · Get Rating · Component Grades · Latest SELB News From Around the Web. Set realtime stock alerts on Selecta Biosciences Inc. Stock Alarm provides SELB prices, fundamentals, technicals, news, and more. Get the LIVE share price of Selecta Biosciences Inc(SELB) and stock performance in one place to strengthen your trading strategy in US stocks. The Selecta Biosciences stock prediction for is currently $ , assuming that Selecta Biosciences shares will continue growing at the average yearly. Selecta Biosciences Inc. (SELB) · Selecta Biosciences Inc. (SELB) Share Price · High:$ Low:$ Return: up-down-arrow % · Max: loading Min: loading. RNAC Selecta Biosciences Inc. 7, $ $ (%). Today. Watchers, 7, Wk Low, $ Wk High, $ Market Cap, $M. Selecta Biosciences Inc (NASDAQ:SELB) institutional ownership structure shows current positions in the company by institutions and funds, as well as latest.
Legal Name Selecta Biosciences, Inc. Selecta Biosciences is a biopharmaceutical company developing the first generation of nanoparticle immunomodulatory drugs. Selecta Biosciences reported an EPS of -$ in its last earnings report, beating expectations of -$ Following the earnings report the stock price went. Opening hours (GMT -) ; Selecta Biosciences, Inc. - SELB Stock Chart Technical Analysis for 10/21/ - ; ; Selecta Biosciences, Inc. -. Selecta Biosciences Inc. is an equity that has experienced a negative one-year annualized return of % as of November 30, The biotech company Selecta Biosciences Inc trades as SELB stock on the Nasdaq All Markets. Selecta Biosciences, Inc. is a clinical-stage biopharmaceutical.
Fundamental Analysis of SELECTA BIOSCIENCES INC(NASDAQ:SELB) stock. Fundamental Analysis of Growth, Valuation, Profitibility, Health and Dividend. Selecta Biosciences Inc. (Nasdaq: SELB) News & Media - Detail View · Organogenesis Shares ReNu® Program Update. WATERTOWN, Mass., July 28, (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. How much is Selecta Biosciences stock worth? Invest with precise valuations. SELB Selecta Biosciences Inc ; 52, , , , ; , , , , Selecta Biosciences (NASDAQ:SELB - Get Free Report) announced its earnings results on Thursday. The company reported ($) earnings per share (EPS) for.